Kimberly Firtz, PharmD, MSPBA Candidate

Pharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.

Significant savings on biologic drugs from biosimilars may not be realized until litigation regarding patents is settled.

Collecting data that show the most efficient and effective ways to clinically manage patients is becoming more important than ever in specialty pharmacy.

With new specialty pharmacies emerging and existing pharmacies evolving, accreditation has become more important.

Leaders in specialty pharmacy must work to improve employee engagement in order to boost the customer experience.

The current specialty pharmacy landscape is constantly evolving, requiring a collaborative environment to meet the needs of patients.